InVivoMab anti-mouse ICOS BE0059-R001mg from Bio X Cell

Other available quantities: Available in 1, 5, 10, 25, 50, 100 mg and bulk sizes. Academic discount available.

Endotoxin: <2EU/mg (<0.002EU/µg), Determined by LAL gel clotting assay

39 Labombard Rd

Lebanon, NH 03766

United States

Phone: 1-866-787-3444

Email: customerservice@bxcell.com

(1) RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic CancerCancer cellNovember 12, 2018Wang W, Marinis JM, Beal AM, Savadkar S, Wu Y, Khan M, Taunk PS, Wu N, Su W, Wu J, et al.

(2) LAG3⁺ Regulatory T Cells Restrain Interleukin-23-Producing CX3CR1⁺ Gut-Resident Macrophages during Group 3 Innate Lymphoid Cell-Driven ColitisImmunityAugust 21, 2018Bauché D, Joyce-Shaikh B, Jain R, Grein J, Ku KS, Blumenschein WM, Ganal-Vonarburg SC, Wilson DC, McClanahan TK, Malefyt RW, et al.

(5) Central memory CD8+ T lymphocytes mediate lung allograft acceptanceThe Journal of clinical investigationMarch 1, 2014Krupnick AS, Lin X, Li W, Higashikubo R, Zinselmeyer BH, Hartzler H, Toth K, Ritter JH, Berezin MY, Wang ST, et al.

(6) CD40-independent help by memory CD4 T cells induces pathogenic alloantibody but does not lead to long-lasting humoral immunityAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant SurgeonsNovember 1, 2013Rabant M, Gorbacheva V, Fan R, Yu H, Valujskikh A.

(7) CTLA4-Ig restores rejection of MHC class-II mismatched allografts by disabling IL-2-expanded regulatory T cellsAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant SurgeonsSeptember 1, 2012Charbonnier LM, Vokaer B, Lemaître PH, Field KA, Leo O, Le Moine A.

(8) CD4(+) type II NKT cells mediate ICOS and programmed death-1-dependent regulation of type 1 diabetesJournal of immunology (Baltimore, Md. : 1950)April 1, 2012Kadri N, Korpos E, Gupta S, Briet C, Löfbom L, Yagita H, Lehuen A, Boitard C, Holmberg D, Sorokin L, et al.

InVivoMab anti-mouse ICOS